Therapeutic effect of taurine against aluminum-induced impairment on learning, memory and brain neurotransmitters in rats
Springer-Verlag Italia
Abstract
Springer-Verlag Italia
Abstract
The aim of the study was to demonstrate the therapeutic effect of taurine against aluminum (Al)- induced neurological disorders in rats. Forty-two Wistar rats were randomly allotted into six groups: control (saline only), Al exposure (281.4 mg/kg/day for 1 month), Al ? taurine (Al administration as previously plus taurine, doses were 200, 400 and 800 mg/kg/day, respectively, for the next 1 month) and prevention group (along with the Al administration as previously, 400 mg/kg/day taurine was treated for 1 month. During the next 1 month, rats were given taurine 400 mg/kg/day only). Starting from the sixth week, the body weight gain was significantly reduced in Al exposure group compared with saline (P 0.05), and at the eighth week, the gain in prevention group was increased compared with Al (P 0.05). Brain coefficient was gained in Al exposure compared with saline or pre- vention group (P 0.05). Al exposure resulted in learning and memory impairment by increasing the escape latency and searching distance, meanwhile, decreasing the swim- ming time in the quadrant of platform and the numbers of crossing the platform (P 0.05). Unsurprisingly, taurine treatment (400, 800 mg/kg/day and prevention) signifi- cantly protected against Al-induced brain dysfunction (P 0.05). The Al exposure led to significant decreases in levels of c-GABA and Tau, meanwhile, increased in level of Asp and Glu compared with saline (P 0.05). And yet, taurine treatment partially reversed the deteriorated chan- ges. The results suggested that taurine probably has neu- roprotective effect against Al-induced learning, memory and brain neurotransmitters dysfunction.
OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The aim of the study was to demonstrate the therapeutic effect of taurine against aluminum (Al)- induced neurological disorders in rats. Forty-two Wistar rats were randomly allotted into six groups: control (saline only), Al exposure (281.4 mg/kg/day for 1 month), Al ? taurine (Al administration as previously plus taurine, doses were 200, 400 and 800 mg/kg/day, respectively, for the next 1 month) and prevention group (along with the Al administration as previously, 400 mg/kg/day taurine was treated for 1 month. During the next 1 month, rats were given taurine 400 mg/kg/day only). Starting from the sixth week, the body weight gain was significantly reduced in Al exposure group compared with saline (P 0.05), and at the eighth week, the gain in prevention group was increased compared with Al (P 0.05). Brain coefficient was gained in Al exposure compared with saline or pre- vention group (P 0.05). Al exposure resulted in learning and memory impairment by increasing the escape latency and searching distance, meanwhile, decreasing the swim- ming time in the quadrant of platform and the numbers of crossing the platform (P 0.05). Unsurprisingly, taurine treatment (400, 800 mg/kg/day and prevention) signifi- cantly protected against Al-induced brain dysfunction (P 0.05). The Al exposure led to significant decreases in levels of c-GABA and Tau, meanwhile, increased in level of Asp and Glu compared with saline (P 0.05). And yet, taurine treatment partially reversed the deteriorated chan- ges. The results suggested that taurine probably has neu- roprotective effect against Al-induced learning, memory and brain neurotransmitters dysfunction.
Key concepts: Taurine, Saline, Internal medicine, Endocrinology, Medicine, Chemistry, Animal science, Biology